XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021     113,621,000      
Beginning balance at Dec. 31, 2021 $ 285,998   $ 11 $ 779,212 $ 16 $ (493,241)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)     201,000      
Stock option exercises 1,866     1,866    
Restricted stock unit releases (in shares)     147,000      
Stock-based compensation 27,144     27,144    
Other comprehensive income 8       8  
Net income (loss) (34,133)         (34,133)
Ending balance (in shares) at Mar. 31, 2022     113,969,000      
Ending balance at Mar. 31, 2022 280,883   $ 11 808,222 24 (527,374)
Beginning balance (in shares) at Dec. 31, 2021     113,621,000      
Beginning balance at Dec. 31, 2021 285,998   $ 11 779,212 16 (493,241)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (90,142)          
Ending balance (in shares) at Sep. 30, 2022     114,859,000      
Ending balance at Sep. 30, 2022 283,959   $ 11 867,754 (423) (583,383)
Beginning balance (in shares) at Mar. 31, 2022     113,969,000      
Beginning balance at Mar. 31, 2022 280,883   $ 11 808,222 24 (527,374)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)     128,000      
Stock option exercises 1,689     1,689    
Restricted stock unit releases (in shares)     177,000      
Stock Issued During Period, Value, Employee Stock Purchase Plan 1,754     1,754    
Shares issued in connection with employee stock purchase plan (in shares)     118,000      
Stock-based compensation 26,764     26,764    
Stock Issued During Period, Value, Non-cash Charitable Contribution 3,270     3,270    
Non-cash charitable contributions (in shares)     179,000      
Other comprehensive income (163)       (163)  
Net income (loss) (32,166)         (32,166)
Ending balance (in shares) at Jun. 30, 2022     114,571,000      
Ending balance at Jun. 30, 2022 282,031   $ 11 841,699 (139) (559,540)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)     135,000      
Stock option exercises 1,709     1,709    
Restricted stock unit releases (in shares)     151,000      
Proceeds from repayment of related party loans 45     45    
Proceeds from repayment of related party loans (in shares)     2,000      
Stock-based compensation 24,301     24,301    
Other comprehensive income (284)       (284)  
Net income (loss) (23,843)         (23,843)
Ending balance (in shares) at Sep. 30, 2022     114,859,000      
Ending balance at Sep. 30, 2022 283,959   $ 11 867,754 (423) (583,383)
Beginning balance (in shares) at Dec. 31, 2022     115,339,000      
Beginning balance at Dec. 31, 2022 286,646   $ 12 890,915 (647) (603,634)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)     109,000      
Stock option exercises 1,415     1,415    
Restricted stock unit releases (in shares)     153,000      
Stock-based compensation 19,780     19,780    
Other comprehensive income (683)       (683)  
Net income (loss) (10,812)         (10,812)
Ending balance (in shares) at Mar. 31, 2023     115,601,000      
Ending balance at Mar. 31, 2023 296,346   $ 12 912,110 (1,330) (614,446)
Beginning balance (in shares) at Dec. 31, 2022     115,339,000      
Beginning balance at Dec. 31, 2022 $ 286,646   $ 12 890,915 (647) (603,634)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares) 727,932          
Net income (loss) $ (44,150)          
Ending balance (in shares) at Sep. 30, 2023     117,259,000      
Ending balance at Sep. 30, 2023 304,611   $ 12 954,019 (1,636) (647,784)
Beginning balance (in shares) at Mar. 31, 2023     115,601,000      
Beginning balance at Mar. 31, 2023 296,346   $ 12 912,110 (1,330) (614,446)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)     482,000      
Stock option exercises 1,940     1,940    
Restricted stock unit releases (in shares)     285,000      
Stock Issued During Period, Value, Employee Stock Purchase Plan 1,124     1,124    
Shares issued in connection with employee stock purchase plan (in shares)   117,000        
Stock-based compensation 18,012     18,012    
Stock Issued During Period, Value, Non-cash Charitable Contribution 600     600    
Non-cash charitable contributions (in shares)   57,000        
Other comprehensive income (35)       (35)  
Net income (loss) (15,925)         (15,925)
Ending balance (in shares) at Jun. 30, 2023     116,542,000      
Ending balance at Jun. 30, 2023 302,062   $ 12 933,786 (1,365) (630,371)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)     137,000      
Stock option exercises 1,351     1,351    
Restricted stock unit releases (in shares)     401,000      
Stock-based compensation 16,291     16,291    
Stock Issued During Period, Value, Non-cash Charitable Contribution 2,591     2,591    
Non-cash charitable contributions (in shares)   179,000        
Other comprehensive income (271)       (271)  
Net income (loss) (17,413)         (17,413)
Ending balance (in shares) at Sep. 30, 2023     117,259,000      
Ending balance at Sep. 30, 2023 $ 304,611   $ 12 $ 954,019 $ (1,636) $ (647,784)